Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.24 million on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lucid Diagnostics
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In the meantime, Ascendiant Capital Markets initiated its Lucid Diagnostics Inc [LUCD] rating to a Buy in a research note
While this happened, Ascendiant Capital Markets initiated its Lucid Diagnostics Inc [LUCD] rating to a Buy in a research note